EA201890570A1 - [4-(1,3,3-триметил-2-оксо-3,4-дигидро-1h-хиноксалин-7-ил)фенокси]этилокси соединение или его соль - Google Patents
[4-(1,3,3-триметил-2-оксо-3,4-дигидро-1h-хиноксалин-7-ил)фенокси]этилокси соединение или его сольInfo
- Publication number
- EA201890570A1 EA201890570A1 EA201890570A EA201890570A EA201890570A1 EA 201890570 A1 EA201890570 A1 EA 201890570A1 EA 201890570 A EA201890570 A EA 201890570A EA 201890570 A EA201890570 A EA 201890570A EA 201890570 A1 EA201890570 A1 EA 201890570A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- salt
- trimethyl
- oxo
- digidro
- penoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
- C07F9/650994—Six-membered rings having the nitrogen atoms in the positions 1 and 4 condensed with carbocyclic rings or carbocyclic ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Настоящее изобретение относится к новому [4-(1,3,3-триметил-2-оксо-3,4-дигидро-1H-хиноксалин-7-ил)фенокси]этилокси соединению или его соли. Соединение или его соль настоящего изобретения обладает агонистической активностью относительно глюкокортикоидного рецептора и является пригодным в качестве лекарственного средства, в частности в качестве профилактического или терапевтического агента для заболевания, связанного с глюкокортикоидным рецептором.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015166247 | 2015-08-25 | ||
PCT/JP2016/074863 WO2017034006A1 (ja) | 2015-08-25 | 2016-08-25 | [4-(1,3,3-トリメチル-2-オキソ-3,4-ジヒドロ-1h-キノキサリン-7-イル)フェノキシ]エチルオキシ化合物またはその塩 |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201890570A1 true EA201890570A1 (ru) | 2018-08-31 |
Family
ID=58100493
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201890570A EA201890570A1 (ru) | 2015-08-25 | 2016-08-25 | [4-(1,3,3-триметил-2-оксо-3,4-дигидро-1h-хиноксалин-7-ил)фенокси]этилокси соединение или его соль |
Country Status (9)
Country | Link |
---|---|
US (3) | US10189796B2 (ru) |
EP (1) | EP3342768A4 (ru) |
JP (2) | JP2017043614A (ru) |
KR (1) | KR20180043329A (ru) |
CN (1) | CN107922356A (ru) |
CA (1) | CA2996278A1 (ru) |
EA (1) | EA201890570A1 (ru) |
HK (1) | HK1252159A1 (ru) |
WO (1) | WO2017034006A1 (ru) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2996278A1 (en) * | 2015-08-25 | 2017-03-02 | Santen Pharmaceutical Co., Ltd. | [4-(1,3,3-trimethyl-2-oxo-3,4-dihydro-1h-quinoxalin-7-yl)-phenoxy]ethyloxy compound or salt thereof |
EP3639854A4 (en) | 2017-06-16 | 2021-03-03 | The Doshisha | MTOR INHIBITIVE MEDICINAL PRODUCT FOR THE TREATMENT OR PREVENTION OF OPHTHALMIC SYMPTOMS, DISORDERS, OR DISEASES AND USE THEREOF |
WO2018230713A1 (ja) | 2017-06-16 | 2018-12-20 | 学校法人同志社 | カスパーゼ阻害活性を有する化合物、これらの化合物を含む、角膜内皮の症状、障害または疾患を治療または予防するための医薬およびその応用 |
AR113967A1 (es) | 2017-12-18 | 2020-07-01 | Gruenenthal Gmbh | Pirrolidinamidas i sustituidas |
TW201927769A (zh) | 2017-12-18 | 2019-07-16 | 德商歌林達有限公司 | 經取代之吡咯啶醯胺ii |
SI3823971T1 (sl) | 2018-07-20 | 2022-10-28 | Gruenenthal Gmbh | Substituirani derivati triazolokinoksalina |
TWI811400B (zh) | 2018-07-20 | 2023-08-11 | 德商歌林達有限公司 | 經進一步取代之三唑并喹噁啉衍生物 |
MX2021008364A (es) | 2019-01-11 | 2021-08-05 | Gruenenthal Gmbh | Amidas de pirrolidina iii sustituidas. |
WO2020254552A2 (en) | 2019-06-19 | 2020-12-24 | Grünenthal GmbH | Substituted pyrrolidine amides v |
ES2946888T3 (es) | 2019-06-19 | 2023-07-27 | Gruenenthal Gmbh | Pirrolidina-amidas sustituidas IV |
WO2021144440A1 (en) | 2020-01-17 | 2021-07-22 | Grünenthal GmbH | Quinoxaline derivatives as modulators of the glucocorticoid receptor |
EP4090660B1 (en) | 2020-01-17 | 2024-01-31 | Grünenthal GmbH | Quinoxaline derivatives |
US20230265078A1 (en) | 2020-07-09 | 2023-08-24 | Gruenenthal Gmbh | Substituted pyrrolidine amines and amides vi |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1201660B1 (en) | 2000-10-30 | 2005-08-31 | Pfizer Products Inc. | Glucocorticoid receptor modulators |
JP5054996B2 (ja) * | 2006-03-14 | 2012-10-24 | 参天製薬株式会社 | グルココルチコイド受容体結合活性を有する新規1,2,3,4−テトラヒドロキノキサリン誘導体 |
PT1995242E (pt) * | 2006-03-14 | 2012-11-22 | Santen Pharmaceutical Co Ltd | Novos derivados de 1,2,3,4-tetra-hidroquinoxalina tendo actividade de ligação ao receptor de glucocorticóides |
KR20100022456A (ko) * | 2007-05-29 | 2010-03-02 | 산텐 세이야꾸 가부시키가이샤 | 글루코코르티코이드 수용체 결합 활성을 갖는, 술폰산에스테르 또는 술폰산아미드 구조를 도입한 페닐기를 치환기로서 갖는 신규 1,2,3,4-테트라히드로퀴녹살린 유도체 |
JP2009084274A (ja) | 2007-09-13 | 2009-04-23 | Santen Pharmaceut Co Ltd | 新規1,3,3−トリメチル−7−フェニル−3,4−ジヒドロ−1h−キノキサリン−2−オン誘導体 |
JP2009084273A (ja) | 2007-09-13 | 2009-04-23 | Santen Pharmaceut Co Ltd | 1,3,3−トリメチル−7−フェニル−3,4−ジヒドロ−1h−キノキサリン−2−オン誘導体からなるグルココルチコイド受容体アゴニスト |
UA102101C2 (ru) | 2008-05-12 | 2013-06-10 | Сантен Фармасьютикал Ко., Лтд. | Агонист глюкокортикоидного рецептора, который содержит 2,2,4-триметил-6-фенил-1,2-дигидрохинолиновые производные, которые имеют замещенную оксигруппу |
BRPI0924571A2 (pt) | 2008-09-12 | 2016-08-09 | Santen Pharmaceutical Co Ltd | agonista de receptor de glicocorticóide, composição farmacêutica, agente terapêutico para doença inflamatória, agente terapêutico para doença inflamatória ocular, agente terapêutico para distúrbio osso-junta inflamatório, método para tratar doença inflamatória, método para tratar doença inflamatória ocular, e método para tratar distúrbio oss-junta inflamatório |
CA2996278A1 (en) * | 2015-08-25 | 2017-03-02 | Santen Pharmaceutical Co., Ltd. | [4-(1,3,3-trimethyl-2-oxo-3,4-dihydro-1h-quinoxalin-7-yl)-phenoxy]ethyloxy compound or salt thereof |
-
2016
- 2016-08-25 CA CA2996278A patent/CA2996278A1/en not_active Abandoned
- 2016-08-25 EP EP16839353.6A patent/EP3342768A4/en not_active Withdrawn
- 2016-08-25 KR KR1020187008105A patent/KR20180043329A/ko not_active Application Discontinuation
- 2016-08-25 EA EA201890570A patent/EA201890570A1/ru unknown
- 2016-08-25 WO PCT/JP2016/074863 patent/WO2017034006A1/ja active Application Filing
- 2016-08-25 US US15/753,410 patent/US10189796B2/en active Active
- 2016-08-25 JP JP2016164830A patent/JP2017043614A/ja active Pending
- 2016-08-25 CN CN201680049254.XA patent/CN107922356A/zh active Pending
-
2018
- 2018-09-07 HK HK18111552.7A patent/HK1252159A1/zh unknown
- 2018-12-05 US US16/210,163 patent/US10435379B2/en not_active Expired - Fee Related
-
2019
- 2019-08-06 US US16/532,533 patent/US20190359577A1/en not_active Abandoned
-
2021
- 2021-05-28 JP JP2021089664A patent/JP7037687B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
US20190359577A1 (en) | 2019-11-28 |
US10189796B2 (en) | 2019-01-29 |
JP2021138728A (ja) | 2021-09-16 |
US20180244633A1 (en) | 2018-08-30 |
CA2996278A1 (en) | 2017-03-02 |
CN107922356A (zh) | 2018-04-17 |
US20190106393A1 (en) | 2019-04-11 |
JP7037687B2 (ja) | 2022-03-16 |
US10435379B2 (en) | 2019-10-08 |
EP3342768A4 (en) | 2019-01-23 |
HK1252159A1 (zh) | 2019-05-17 |
EP3342768A1 (en) | 2018-07-04 |
WO2017034006A1 (ja) | 2017-03-02 |
KR20180043329A (ko) | 2018-04-27 |
JP2017043614A (ja) | 2017-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201890570A1 (ru) | [4-(1,3,3-триметил-2-оксо-3,4-дигидро-1h-хиноксалин-7-ил)фенокси]этилокси соединение или его соль | |
MX2021007432A (es) | Compuestos y composiciones para inhibir la actividad de shp2. | |
SG11201806930PA (en) | Novel condensed pyrimidine compound or salt thereof | |
EA201692301A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
PH12016501966A1 (en) | Compounds and compositions as toll-like receptor 7 agonists | |
EA201691988A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
TN2016000268A1 (en) | N-azaspirocycloalkane substituted n-heteroaryl compounds and compositions for inhibiting the activity of shp2. | |
MX2016014308A (es) | Compuestos y composiciones como agonistas del receptor tipo toll 7. | |
EA201591745A1 (ru) | 3-пиримидин-4-ил-оксазолидин-2-оны в качестве ингибиторов мутантого idh | |
BR112018006866A2 (pt) | compostos agonistas de ppar, composições farmacêuticas e métodos de uso dos mesmos | |
CL2016002072A1 (es) | 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahidropiridinas como inhibidores de bace1 para el tratamiento de la enfermedad de alzheimer | |
EA201690629A1 (ru) | Соединения, которые представляют собой тройные агонисты, глюкагона, glp-1 и gip | |
EA201690848A1 (ru) | Производные бициклического пиридила с конденсированными кольцами в качестве ингибиторов fgfr4 | |
EA201591727A1 (ru) | Соединения биариламида в качестве ингибиторов киназы | |
PH12017500401A1 (en) | Therapeutic compounds as inhibitors of the orexin-1 receptor | |
EA201501142A1 (ru) | Гетероциклические соединения в качестве средств для борьбы с вредителями | |
PH12017501095A1 (en) | Piperidine derivatives as hdac1/2 inhibitors | |
EA201400161A1 (ru) | Замещенные гетероароматические пиразолсодержащие карбоксамидные и мочевинные производные в качестве лигандов ваниллоидных рецепторов | |
EA201590562A1 (ru) | Бензамиды | |
EA201890449A1 (ru) | Фумагиллиновые гетероциклические соединения и способы их получения и применения | |
PL410665A1 (pl) | Inhibitory arginazy oraz ich zastosowania terapeutyczne | |
EA201692481A1 (ru) | Комбинация, содержащая глюкокортикоид и edo-s101 | |
WO2016004404A3 (en) | Gls1 inhibitors for treating disease | |
BR112016028037A2 (pt) | Novos compostos | |
EA201790070A1 (ru) | Бифениламиды, содержащие модифицированные простые эфирные группы, в качестве ингибиторов hsp90 и стимуляторов hsp70 |